TABLE OF CONTENTS
Volume 43, Issue 5 (March (1) 2009)
Editorial
To G or not to G: is this still a question in allogeneic transplantation?
N Hawk and H J Khoury
Bone Marrow Transplant 43: 349; doi:10.1038/bmt.2008.444
Review
Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice
M Battiwalla and P L McCarthy
Bone Marrow Transplant 43: 351-356; advance online publication, February 2, 2009; doi:10.1038/bmt.2008.443
Original Articles
Stem Cell Collection
Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study
G C Leitner, K Baumgartner, P Kalhs, D Biener, H T Greinix, P Hoecker and N Worel
Bone Marrow Transplant 43: 357-363; advance online publication, October 20, 2008; doi:10.1038/bmt.2008.335
Cord Blood Stem Cells
Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor
G Bautista, J R Cabrera, C Regidor, R Forés, J A García-Marco, E Ojeda, I Sanjuán, E Ruiz, I Krsnik, B Navarro, S Gil, E Magro, A de Laiglesia, R Gonzalo-Daganzo, T Martín-Donaire, M Rico, I Millán and M N Fernández
Bone Marrow Transplant 43: 365-373; advance online publication, October 13, 2008; doi:10.1038/bmt.2008.329
Pediatric Transplants
Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005
M Sauer, B Meissner, D Fuchs, B Gruhn, H Kabisch, R Erttmann, M Suttorp, A Beilken, T Luecke, K Welte, L Grigull and K W Sykora
Bone Marrow Transplant 43: 375-381; advance online publication, October 13, 2008; doi:10.1038/bmt.2008.328
Allografting
Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 
anti-CD20 antibody and donor lymphocyte infusion
R Buhmann, B Simoes, M Stanglmaier, T Yang, M Faltin, D Bund, H Lindhofer and H-J Kolb
Bone Marrow Transplant 43: 383-397; advance online publication, October 13, 2008; doi:10.1038/bmt.2008.323
CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT
M Kapp, S Stevanovi
, K Fick, S M Tan, J Loeffler, A Opitz, T Tonn, G Stuhler, H Einsele and G U Grigoleit
Bone Marrow Transplant 43: 399-410; advance online publication, January 12, 2009; doi:10.1038/bmt.2008.426
Autografting
Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit
M A Trinkaus, S E Lapinsky, M Crump, A Keating, D E Reece, C Chen, D C Hallett, N Franke, A Winter and J R Mikhael
Bone Marrow Transplant 43: 411-415; advance online publication, October 20, 2008; doi:10.1038/bmt.2008.336
Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma
R L Olin, D T Vogl, D L Porter, S M Luger, S J Schuster, D E Tsai, D L Siegel, R J Cook, P A Mangan, K Cunningham and E A Stadtmauer
Bone Marrow Transplant 43: 417-422; advance online publication, October 13, 2008; doi:10.1038/bmt.2008.334
Graft-Versus-Host Disease
Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience
M Miano, D Cuzzubbo, P Terranova, S Giardino, E Lanino, G Morreale, E Castagnola, G Dini and M Faraci
Bone Marrow Transplant 43: 423-427; advance online publication, October 13, 2008; doi:10.1038/bmt.2008.331
Letter to the Editor
Donor cell-derived myelodysplastic syndrome after cord blood transplantation
T Konuma, J Ooi, S Takahashi, A Tomonari, N Tsukada, S Kato, A Sato, F Monma, E Hongo, K Uchimaru, A Tojo and S Asano
Bone Marrow Transplant 43: 429-431; advance online publication, November 3, 2008; doi:10.1038/bmt.2008.344
